Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics.
Cells
; 11(21)2022 10 25.
Article
in En
| MEDLINE
| ID: mdl-36359767
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Alzheimer Disease
/
Sodium-Glucose Transporter 2 Inhibitors
/
Ketosis
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cells
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland